肝脏移植

预约门诊
打印

科室与专家门诊

妙佑医疗国际是美国规模最大、经验最丰富的医疗机构之一，在亚利桑那州、佛罗里达州和明尼苏达州都设有院区。我们的工作人员涉及数十种专业，通过齐心协力确保高品质治疗与成功康复。

有相关专长的科室

行此手术的医生

编辑搜索过滤条件
close

缩小搜索范围

重置所有过滤器

显示$起始范围 - $结束范围/源自可用$可用医生

姓氏首字母: Y

  1. Liu Yang, M.B.B.S.

    Liu Yang, M.B.B.S.

    1. Transplant Hepatologist
    1. Jacksonville, FL
    擅长领域：

    Liver transplant, Post-transplant long-term care, Pre-transplant evaluation, Cirrhosis, Liver problems, Primary scleros...ing cholangitis, Cholangiocarcinoma, Liver cancer, Alcoholic hepatitis, Hepatocellular carcinoma, Hepatopulmonary syndrome, Primary biliary cholangitis, Nonalcoholic fatty liver disease, Cholestasis of pregnancy

  2. Maria L. Yataco, M.D.

    Maria L. Yataco, M.D.

    1. Transplant Hepatologist
    1. Jacksonville, FL
    擅长领域：

    Liver transplant, Post-transplant long-term care, Pre-transplant evaluation, Cirrhosis, Liver problems, Primary scleros...ing cholangitis, Cholangiocarcinoma, Liver cancer, Alcoholic hepatitis, Acute liver failure, Hepatocellular carcinoma, Hepatopulmonary syndrome, Primary biliary cholangitis, Nonalcoholic fatty liver disease, Hepatitis infectious disease

研究

妙佑医疗国际的科学家、医生和外科医生提出了肝脏移植的见解和创新理念，让移植更安全并适合更多的患者。他们积极参与肝移植相关各方面医疗状况的实验室研究、临床试验及其他研究。

下面是一些示例：

  • 生物人工肝脏。该创新技术帮助患者从容应对肝脏移植的等待过程。妙佑医疗国际的医生和研究人员开发的新型生物人工肝脏使用猪肝的活细胞来过滤患者血液，整个过程类似于肾脏透析。该设备正在接受测试，之后将推广至医疗中心和医院。
  • 磁共振弹性成像。该创新技术由妙佑医疗国际的医生和研究人员研发，是一种用于检测肝瘢痕形成的非侵入性方法。这种技术未来有望减少肝病患者进行肝活检的需要。
  • 免疫抑制药物。该研究考察了肝肾移植中抗体介导损伤的影响，以及如何进行多器官移植才能产生更好的效果。
  • 充分扩大器官捐献者群体。移植医生发现，相较于脑死亡患者的捐献器官，心源性死亡患者的捐献器官能为肝癌患者带来同样的有益效果。
  • 肝病的细胞疗法。这项研究为几种肝病提供了潜在的新疗法，并有可能提高肝移植的成功率。
  • 分诊系统。妙佑医疗国际研究人员最先提出、设计并测试了终末期肝病（MELD）的模型。该系统根据患者状况的严重程度及其需要移植的紧急程度，对等待移植的患者进行优先排序。

详细了解移植研究中心所支持的许多肝移植研究。

文献

请参阅美国国家医学图书馆检索服务系统 PubMed 所收录的妙佑医疗国际医生在肝移植领域的文献著述列表。

Research Profiles

来自妙佑医疗国际员工

在 Mayo Clinic 治疗

申请预约
关于在 Mayo Clinic 治疗
Jan. 19, 2024
打印
  1. AskMayoExpert. Liver transplantation (child). Mayo Clinic; 2021.
  2. Liver transplant. American Liver Foundation. https://liverfoundation.org/for-patients/about-the-liver/liver-transplant/#what-can-people-do-to-help-those-who-need-liver-transplants. Accessed Oct. 14, 2019.
  3. The progression of liver disease. American Liver Foundation. https://liverfoundation.org/for-patients/about-the-liver/the-progression-of-liver-disease/#doctors-visit-guide. Accessed Aug. 24, 2021.
  4. Waiting for your transplant. UNOS Transplant Living. https://transplantliving.org/before-the-transplant/waiting-for-your-transplant/. Accessed Aug. 23, 2021.
  5. Busuttil RW, et al., eds. Donor selection and management. In: Transplantation of the Liver. 3rd ed. Saunders Elsevier; 2015. https://www.clinicalkey.com. Accessed Oct. 14, 2019.
  6. Side effects. UNOS Transplant Living. https://transplantliving.org/after-the-transplant/preventing-rejection/side-effects/. Accessed Aug. 23, 2021.
  7. Dove LM, et al. Liver transplantation in adults: Patient selection and pretransplantation evaluation. https://www.uptodate.com/contents/search. Accessed Oct. 14, 2019.
  8. Bambha K, et al. Model for End-Stage Liver Disease (MELD). https://www.uptodate.com/contents/search. Accessed Oct. 14, 2019.
  9. Cotler S. Living donor liver transplantation. https://www.uptodate.com/contents/search. Accessed Oct. 14, 2019.
  10. Lerut J, et al. Domino-liver transplantation: Toward a safer and simpler technique in both donor and recipient. Updates in Surgery. 2021; doi:10.1007/s13304-020-00886-4.
  11. Kwong A, et al. OPTN/SRTR 2018 annual data report: Liver. American Journal of Transplantation. 2020; doi:10.1111/ajt.15674.
  12. Croome KP, et al. The use of donation after cardiac death allografts does not increase recurrence of hepatocellular carcinoma. American Journal of Transplantation. 2015; doi:10.1111/ajt.13306.
  13. Zhou W, et al. Stem cell-related studies and stem cell-based therapies in liver disease. Cell Transplantation. 2019; doi:10.1177/0963689719859262.
  14. Preventing rejection. UNOS Transplant Living. https://transplantliving.org/after-the-transplant/preventing-rejection/. Accessed Aug. 23, 2021.
  15. Why join a support group. UNOS Transplant Living. https://transplantliving.org/community/support-groups/. Accessed Aug. 23, 2021.
  16. Chen HS, et al. Randomized trial of spheroid reservoir bioartificial liver in porcine model of posthepatectomy liver failure. Hepatology. 209; doi:10.1002/hep.30184.
  17. Ferri FF. Ferri's Clinical Advisor 2022. Elsevier; 2022. https://www.clinicalkey.com. Accessed Aug. 24, 2021.
  18. Liver transplantation. Merck Manual Professional Version. https://www.merckmanuals.com/professional/immunology-allergic-disorders/transplantation/liver-transplantation?query=liver transplantation#. Accessed Aug. 24, 2021.
  19. Feather A, et al., eds. Liver disease. In: Kumar & Clark's Clinical Medicine. 10th ed. Elsevier; 2021. https://www.clinicalkey.com. Accessed Aug. 24, 2021.
  20. Overview of transplantation. Merck Manual Professional Version. https://www.merckmanuals.com/professional/immunology-allergic-disorders/transplantation/overview-of-transplantation#. Accessed Aug. 24, 2021.
  21. Burt AD, et al., eds. Transplantation pathology. In: MacSween's Pathology of the Liver. 7th ed. Elsevier; 2018. https://www.clinicalkey.com. Accessed Aug. 31, 2021.
  22. Ekser, B, et al. Current status of combined liver-kidney transplantation. International Journal of Surgery. 2020; doi:10.1016/j.ijsu.2020.02.008.
  23. The organ transplant process. Health Resources and Services Administration. https://www.organdonor.gov/learn/process/transplant-process. Accessed Sept. 7, 2021.

相关

相关医疗程序

Mayo Clinic 新闻

产品与服务

在《美国新闻与世界报道》2023-2024 年度全美最佳消化内科和消化外科医院评选中，妙佑医疗国际明尼苏达州罗切斯特院区位居榜首。

了解更多关于这一最高荣誉的信息

肝脏移植